Cite
HARVARD Citation
Wagner, N. et al. (2019). Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Journal for immunotherapy of cancer. 7 (1), p. . [Online].